Hyogo, Japan

Kenji Kogami



Average Co-Inventor Count = 2.9

ph-index = 1


Location History:

  • Kako-gun, JP (2010)
  • Hyogo, JP (2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kenji Kogami: Innovator in Pharmaceutical Chemistry

Introduction

Kenji Kogami is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for producing optically active compounds. With a total of 2 patents, Kogami's work is recognized for its industrial applicability and cost-effectiveness.

Latest Patents

Kogami's latest patents include a method for producing optically active N-monoalkyl-3-hydroxy-3-arylpropylamine compounds. This invention provides a method that allows for the production of these compounds under advantageous industrial conditions. Another significant patent involves a process for producing N-monoalkyl-3-hydroxy-3-(2-thienyl)propanamine, which serves as an intermediate for various pharmaceuticals. This method emphasizes ease and cost-effectiveness in production.

Career Highlights

Kenji Kogami is associated with Sumitomo Seika Chemicals Co., Ltd., where he has been instrumental in advancing chemical processes. His innovative approaches have contributed to the company's reputation in the pharmaceutical industry. Kogami's work exemplifies the intersection of chemistry and practical application in drug development.

Collaborations

Kogami has collaborated with notable coworkers such as Shuzo Satake and Noriyuki Hayashizaka. These partnerships have fostered a collaborative environment that enhances innovation and research within the company.

Conclusion

Kenji Kogami's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for advancements in drug production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…